These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

234 related articles for article (PubMed ID: 25732053)

  • 21. Neuropathology of variants of progressive supranuclear palsy.
    Dickson DW; Ahmed Z; Algom AA; Tsuboi Y; Josephs KA
    Curr Opin Neurol; 2010 Aug; 23(4):394-400. PubMed ID: 20610990
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Progressive supranuclear palsy as differential diagnosis of Parkinson's disease in the elderly.
    Fernández-Ferreira R; García-Santos RA; Rodríguez-Violante M; López-Martínez C; Becerra-Laparra IK; Torres-Pérez ME
    Rev Esp Geriatr Gerontol; 2019; 54(5):251-256. PubMed ID: 31324404
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [A study on the cerebral glucose metabolism in progressive supranuclear palsy].
    Ma AJ; Guo XJ; Li DC; Zhang BS; Pan XD
    Zhonghua Nei Ke Za Zhi; 2012 Nov; 51(11):885-8. PubMed ID: 23291028
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Incipient progressive supranuclear palsy is more common than expected and may comprise clinicopathological subtypes: a forensic autopsy series.
    Yoshida K; Hata Y; Kinoshita K; Takashima S; Tanaka K; Nishida N
    Acta Neuropathol; 2017 May; 133(5):809-823. PubMed ID: 28064358
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Differentiation of progressive supranuclear palsy: clinical, imaging and laboratory tools.
    Liscic RM; Srulijes K; Gröger A; Maetzler W; Berg D
    Acta Neurol Scand; 2013 May; 127(5):362-70. PubMed ID: 23406296
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A cerebrospinal fluid microRNA analysis: Progressive supranuclear palsy.
    Nonaka W; Takata T; Iwama H; Komatsubara S; Kobara H; Kamada M; Deguchi K; Touge T; Miyamoto O; Nakamura T; Itano T; Masaki T
    Mol Med Rep; 2022 Mar; 25(3):. PubMed ID: 35039873
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Pyramidal system involvement in progressive supranuclear palsy - a clinicopathological correlation.
    Stejskalova Z; Rohan Z; Rusina R; Tesar A; Kukal J; Kovacs GG; Bartos A; Matej R
    BMC Neurol; 2019 Mar; 19(1):42. PubMed ID: 30894142
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Progressive supranuclear palsy with predominant frontal presentation exhibiting progressive nonfluent aphasia due to crossed aphasia.
    Ono Y; Higashida K; Yoshikura N; Hayashi Y; Kimura A; Iwasaki Y; Yoshida M; Shimohata T
    Neuropathology; 2022 Jun; 42(3):232-238. PubMed ID: 35434847
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Corticobasal degeneration and atypical progressive supranuclear palsy: their symptomatology, laboratory examination and differential diagnosis].
    Morimatsu M; Negoro K; Mori H
    Rinsho Shinkeigaku; 2004 Nov; 44(11):982-5. PubMed ID: 15651349
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Recent advances in progressive supranuclear palsy: a review.
    Kaat DL; Chiu WZ; Boon AJ; van Swieten JC
    Curr Alzheimer Res; 2011 May; 8(3):295-302. PubMed ID: 21222597
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Familial aggregation of parkinsonism in progressive supranuclear palsy.
    Donker Kaat L; Boon AJ; Azmani A; Kamphorst W; Breteler MM; Anar B; Heutink P; van Swieten JC
    Neurology; 2009 Jul; 73(2):98-105. PubMed ID: 19458322
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Esophageal achalasia, sleep disorders and chorea in a tauopathy without ophthalmoplegia, parkinsonian syndrome, nor dementia (progressive supranuclear palsy?): clinicopathological study].
    Kaphan E; Pellissier JF; Rey M; Robert D; Auphan M; Ali Chérif A
    Rev Neurol (Paris); 2008 Apr; 164(4):377-83. PubMed ID: 18439931
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Progressive supranuclear palsy].
    Hasegawa K
    Rinsho Shinkeigaku; 1997 Dec; 37(12):1128-30. PubMed ID: 9577667
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Genetics of Progressive Supranuclear Palsy.
    Im SY; Kim YE; Kim YJ
    J Mov Disord; 2015 Sep; 8(3):122-9. PubMed ID: 26413239
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [An 81-year-old woman with progressive motor disturbance, extrapyramidal features, dementia, and oculomotor palsy].
    Urabe T; Mori H; Sumino S; Miwa H; Wakiya M; Shirai T; Takubo H; Mizuno Y
    No To Shinkei; 1998 Mar; 50(3):291-301. PubMed ID: 9566008
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Survival in progressive supranuclear palsy and frontotemporal dementia.
    Chiu WZ; Kaat LD; Seelaar H; Rosso SM; Boon AJ; Kamphorst W; van Swieten JC
    J Neurol Neurosurg Psychiatry; 2010 Apr; 81(4):441-5. PubMed ID: 20360166
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Functional correlates of vertical gaze palsy and other ocular motor deficits in PSP: an FDG-PET study.
    Amtage F; Maurer C; Hellwig S; Tüscher O; Kreft A; Weiller C; Rijntjes M; Winkler C; Meyer PT
    Parkinsonism Relat Disord; 2014 Aug; 20(8):898-906. PubMed ID: 24935235
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Locus coeruleus pathology in progressive supranuclear palsy, and its relation to disease severity.
    Kaalund SS; Passamonti L; Allinson KSJ; Murley AG; Robbins TW; Spillantini MG; Rowe JB
    Acta Neuropathol Commun; 2020 Feb; 8(1):11. PubMed ID: 32019605
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [A case of progressive supranuclear palsy showing improvement of rigidity, nuchal dystonia and autonomic failure with trazodone].
    Kato E; Takahashi S; Abe T; Kawamorita A; Tohgi H
    Rinsho Shinkeigaku; 1994 Oct; 34(10):1013-7. PubMed ID: 7834944
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Genetic bases of Progressive Supranuclear Palsy: the MAPT tau disease.
    Borroni B; Agosti C; Magnani E; Di Luca M; Padovani A
    Curr Med Chem; 2011; 18(17):2655-60. PubMed ID: 21568901
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.